ERBEX
HAWTHORN 160 TABLETS
HAWTHORN 160 TABLETS
Secure payment
Discreet and sanitized package
Fast and safe shipping
Description
Description
HAWTHORN
Food supplement with hawthorn that promotes normal cardiovascular function and blood pressure; promotes relaxation and mental well-being.
Ingredients
Hawthorn (Crataegus oxyacantha L.) flowers and leaves micronized powder; bulking agents: corn starch, microcrystalline cellulose; anti-caking agents: magnesium salts of fatty acids; silicon dioxide.
Nutritional characteristics
| Average values | for 4 tablets |
| Hawthorn flower oil extract in sunflower oil | 984 mg |
How to use
It is recommended to take 1-2 tablets twice a day.
Warnings
Do not exceed the recommended daily dose. Food supplements should not be used as a substitute for a varied, balanced diet and a healthy lifestyle. Keep out of reach of children under three years of age.
Conservation
Store in a cool, dry place, away from heat sources.
Format
Pack of 160 tablets.
Net weight: 48 g.
ERBEX
HAWTHORN 160 TABLETS
HAWTHORN 160 TABLETS
Couldn't load pickup availability
Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.
